Liver (AST/ALT) | Renal (Creatinine) | Metabolic (Lipids) | ||||
---|---|---|---|---|---|---|
Annual rate of testing, Median (IQR) | Subjects with ≥ 1 12-month gap | Annual rate of testing, Median (IQR) | Subjects with ≥ 1 12-month gap | Annual rate of testing, Median (IQR) | Subjects with ≥ 1 12-month gap | |
Overall | 2.76 (1.60,3.73) | 22 % | 2.55 (1.44,3.38) | 18 % | 1.42 (0.50,2.52) | 33 % |
First year of cART | 3 (0, 4) | -- | 2 (0, 4) | -- | 1 (0, 3) | -- |
Subsequent years | 2.23 (0.31, 3.41) | -- | 1.78 (0, 3.06) | -- | 0.85 (0, 2.21) | -- |
Region | ||||||
British Columbia | 3.25 (0.82,4.56)*** | 33 %*** | 1.66 (0.41,3.08)*** | 23 %*** | 1.05 (0.22,2.70)** | 24 %*** |
Ontario | 2.53 (1.37,3.53) | 17 % | 2.35 (1.33,3.20) | 14 % | 1.45 (0.50,2.46) | 32 % |
Quebec | 2.88 (2.08,3.56) | 21 % | 2.88 (2.07,3.56) | 17 % | 1.48 (0.66,2.53) | 38 % |
Gender | ||||||
Male | 2.80 (1.65,3.77)* | 21 %*** | 2.59 (1.47,3.41)** | 16 %** | 1.49 (0.57,2.60)*** | 31 %*** |
Female | 2.60 (1.39,3.56) | 29 % | 2.33 (1.17,3.28) | 24 % | 1.02 (0.33,2.09) | 43 % |
Age | ||||||
<55 | 2.73 (1.57,3.71)* | 23 %** | 2.52 (1.43,3.36)** | 18 %** | 1.39 (0.49,2.48)** | 34 %* |
≥55 | 3.03 (1.92,4.10) | 12 % | 2.90 (1.83,3.69) | 9 % | 1.83 (0.79,2.95) | 23 % |
Race | ||||||
Caucasian | 3.03 (1.43,4.16)*** | 24 %*** | 2.49 (1.07,3.44)*** | 21 %*** | 1.64 (0.53,2.85)*** | 31 %** |
Black | 2.73 (1.55,3.74) | 26 % | 2.27 (1.23,3.17) | 18 % | 1.01 (0.43,2.09) | 45 % |
Aboriginal | 2.07 (0.51,3.59) | 45 % | 1.08 (0.28,2.54) | 30 % | 0.45 (0.12,1.95) | 29 % |
Other | 3.38 (2.39,4.40) | 15 % | 2.62 (1.72,3.49) | 12 % | 2.03 (0.75,2.98) | 25 % |
Unknown | 2.64 (1.67,3.43) | 20 % | 2.63 (1.70,3.39) | 16 % | 1.41 (0.52,2.34) | 34 % |
Risk Factor | ||||||
MSM | 2.97 (1.98,3.92)*** | 18 %*** | 2.72 (1.81,3.48)*** | 15 %*** | 1.53 (0.61,2.61)*** | 32 %** |
Non-MSM | 2.59 (1.26,3.68) | 31 % | 2.28 (0.97,3.32) | 24 % | 1.02 (0.31,2.02) | 41 % |
IDU | 2.13 (0.74,3.66)*** | 38 %*** | 1.46 (0.41,3.02)*** | 29 %*** | 0.66 (0.00,1.63)*** | 34 % |
Non-IDU | 2.89 (1.87,3.84) | 21 % | 2.67 (1.79,3.48) | 16 % | 1.45 (0.59,2.52) | 36 % |
Endemic | 2.75 (1.83,3.62) | 22 % | 2.65 (1.87,3.44) | 20 % | 1.21 (0.57,2.12) | 50 %*** |
Non-Endemic | 2.85 (1.63,3.86) | 24 % | 2.58 (1.42,3.43) | 18 % | 1.35 (0.46,2.46) | 33 % |
Unknown Risk Factor | 2.40 (1.35,3.34)*** | 15 %*** | 2.33 (1.34,3.19)** | 14 %* | 1.91 (0.67,2.91)*** | 21 %*** |
Known Risk Factor | 2.83 (1.69,3.81) | 23 % | 2.59 (1.46,3.43) | 18 % | 1.32 (0.48,2.41) | 35 % |
Year of cART Initiation | ||||||
>2005 | 2.77 (1.63,3.72) | 12 %*** | 2.49 (1.21,3.40)* | 9 %*** | 1.21 (0.33,2.30)*** | 23 %*** |
2001-2005 | 2.77 (1.60,3.79) | 27 % | 2.61 (1.66,3.38) | 22 % | 1.66 (0.63,2.72) | 40 % |
2000 | 2.53 (1.36,3.47) | 53 % | 2.51 (1.34,3.25) | 37 % | 1.45 (0.57,2.70) | 49 % |
Baseline CD4 count | ||||||
<200 cells/mm3 | 2.83 (1.62,3.78)*** | 25 % | 2.55 (1.41,3.42)** | 19 % | 1.44 (0.56,2.59)*** | 34 % |
200-350 cells/mm3 | 2.79 (1.71,3.67) | 18 % | 2.61 (1.59,3.33) | 15 % | 1.39 (0.52,2.47) | 31 % |
350-500 cells/mm3 | 2.66 (1.52,3.75) | 21 % | 2.50 (1.56,3.49) | 17 % | 1.48 (0.47,2.56) | 31 % |
>500 cells/mm3 | 2.07 (0.82,3.31) | 28 % | 1.88 (0.00,3.09) | 21 % | 0.88 (0.00,2.09) | 34 % |
Baseline Regimen | ||||||
NNRTI-Based | 2.68 (1.57,3.56)** | 19 %*** | 2.45 (1.36,3.23)* | 16 %** | 1.30 (0.47,2.34)*** | 34 %*** |
Boosted PI-Based | 2.94 (1.59,4.01) | 22 % | 2.60 (1.40,3.52) | 17 % | 1.58 (0.54,2.73) | 28 % |
PI-Based | 2.66 (1.58,3.51) | 30 % | 2.62 (1.70,3.43) | 24 % | 1.31 (0.42,2.36) | 41 % |
Other | 2.95 (1.95,3.69) | 18 % | 2.89 (1.93,3.49) | 15 % | 1.97 (1.11,2.95) | 40 % |
Hepatitis C co-infection | ||||||
HCV+ | 2.38 (0.90,3.86)*** | 36 %*** | 1.82 (0.55,3.32)*** | 28 %*** | 0.88 (0.14,2.08)*** | 35 % |
HCV- | 2.82 (1.77,3.73) | 19 % | 2.63 (1.67,3.39) | 15 % | 1.52 (0.60,2.60) | 32 % |
Hepatitis B co-infection | ||||||
HBV+ | 2.73 (1.49,3.45) | 17 % | 2.63 (1.51,3.30) | 18 % | 1.41 (0.59,2.37) | 35 % |
HBV- | 2.69 (1.74,3.55) | 20 % | 2.65 (1.80,3.43) | 16 % | 1.50 (0.59,2.50) | 36 % |
HCV and IDU status | ||||||
HCV- non-IDU | 2.89 (1.89,3.79)*** | 20 %*** | 2.68 (1.81,3.45)*** | 16 %*** | 1.45 (0.60,2.49)*** | 36 %*** |
HCV+ non-IDU | 3.31 (2.02,4.54) | 25 % | 3.12 (1.76,4.29) | 18 % | 1.78 (0.70,3.18) | 34 % |
HCV- IDU | 2.90 (1.46,4.08) | 23 % | 2.30 (1.01,3.25) | 15 % | 1.21 (0.49,2.32) | 23 % |
HCV+ IDU | 1.83 (0.62,3.60) | 42 % | 1.34 (0.27,2.93) | 33 % | 0.52 (0.00,1.42) | 37 % |
Unknown | 2.45 (1.34,3.39) | 17 % | 2.34 (1.31,3.20) | 16 % | 1.75 (0.57,2.83) | 24 % |